Clinical Trial Update: Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl [Phase 2]

View source ↗

Summary

This is a Phase 2 study evaluating suvorexant as an adjunct to buprenorphine for opioid use disorder in people who use fentanyl; the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Suvorexant (suvorexant)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Suvorexant, Placebo | Phase 2 | Status: RECRUITING